Blog

Global Think Tank on Steatotic Liver Disease

Recent news from Barcelona: As a function of the very first Global Think Tank on Steatotic Liver...

MASLD and Type 2 Diabetes

An article recently published in Diabetes Care highlights the significant interplay between...

Improving QOL For Decompensated Cirrhosis Patients

Consider the article titled "Decompensated Liver Cirrhosis Care" from Gastroenterology &...

Announcing LiverRight Extend™

LiverRight, Inc.  Apr 03, 2025, 09:00 ET - From the AGA Tech Summit in Chicago LiverRight Launches the Extend™ Turnkey Service for GI Practices in the USAGastroenterology Practices Can Go to Same-Week Video Visit Access for Hepatology Patients with the...

read more

Advocacy Thursday: Blue Faery

If you know about Liver Disease - Hepatitis, MASLD/MASH, ALD, PBC - it's likely because of what we call here at LiverRight "The Tremendous Twenty."There are 20 passionate, proud & powerful ADVOCACY organizations in the USA and around the world that have shone a...

read more

MASLD Mortality Risk

In this journal article "Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden" the revelation is that compared with the general population, the risk of death is nearly twice as high in people with...

read more

Follow Us

© Copyright 2025 LiverRight - All Rights Reserved - Cincinnati, Ohio & London, Kentucky